Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone for Periodic Paralysis
ChiCTR-IPR-17010316Phase 4Suspended
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in periodic paralysis (PP) comparing Idebenone with Placebo (2 arms). Primary endpoint: Attack Rate. Started Jan 2017; status: suspended.
02
Drugs
idebenone
03
Conditions
periodic paralysis (PP)
Beyond the preview
Go deeper on ChiCTR-IPR-17010316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010316.